Experiment 889067
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | HAINSWORTH,JD: JOHNSON,DH: FRAZIER,SR: GRECO,FA:. (1989). CHRONIC DAILY ADMINISTRATION OF ORAL ETOPOSIDE-A PHASE I TRIAL.. 7(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | DOSING FOR 21 DAYS IN A PHASE I STUDY. MYELOSUPPRESSION WAS THE DOSE-LIMITING TOXICICITY. ALOPECIA OCCURRED IN MOST PATIENTS; GASTROINTESTINAL AND OTHER TOXICITIES WERE UNCOMMON. |
| Dose amount | 50.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | MAXIMUM TOLERATED DOSE |